Mathieu, L., Shah, S., Pai‐Scherf, L., Larkins, E., Vallejo, J., Li, X., . . . Singh, H. (2021). FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer. Oncologist.
Citação norma ChicagoMathieu, Luckson, et al. "FDA Approval Summary: Atezolizumab and Durvalumab in Combination With Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer." Oncologist 2021.
Deismireacht MLAMathieu, Luckson, et al. "FDA Approval Summary: Atezolizumab and Durvalumab in Combination With Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer." Oncologist 2021.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.